Tuesday, 02 January 2024 12:17 GMT

Avai Bio Inc (QB)


(MENAFN- Baystreet) 11:34 AM EST - Avai Bio Inc (QB): Announced that in collaboration with its joint venture partner, Austrianova, a global biotechnology company, it will present the latest data from its a-Klotho anti-aging therapy. The presentation will take place at the Second Annual Klotho Conference, which focuses on the future of Klotho-based therapies. Avai Bio Inc (QB) shares O are trading up $0.02 at $0.30.

Full Press Release:

MENAFN07042026000212011056ID1110953985



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search